BNP Paribas Financial Markets reduced its stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 29.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 40,688 shares of the health services provider's stock after selling 16,867 shares during the quarter. BNP Paribas Financial Markets owned about 0.07% of Maximus worth $3,037,000 at the end of the most recent reporting period.
Several other institutional investors also recently modified their holdings of the stock. Algert Global LLC grew its position in shares of Maximus by 12.1% during the 4th quarter. Algert Global LLC now owns 187,017 shares of the health services provider's stock worth $13,961,000 after buying an additional 20,215 shares during the period. Freestone Grove Partners LP acquired a new position in shares of Maximus during the 4th quarter worth about $1,718,000. AQR Capital Management LLC grew its position in shares of Maximus by 189.1% during the 4th quarter. AQR Capital Management LLC now owns 423,298 shares of the health services provider's stock worth $31,599,000 after buying an additional 276,859 shares during the period. Northern Trust Corp grew its position in shares of Maximus by 13.2% during the 4th quarter. Northern Trust Corp now owns 815,133 shares of the health services provider's stock worth $60,850,000 after buying an additional 94,858 shares during the period. Finally, Aquatic Capital Management LLC grew its position in shares of Maximus by 128.8% during the 4th quarter. Aquatic Capital Management LLC now owns 15,328 shares of the health services provider's stock worth $1,144,000 after buying an additional 8,628 shares during the period. 97.21% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Separately, StockNews.com cut Maximus from a "buy" rating to a "hold" rating in a report on Thursday.
Check Out Our Latest Stock Report on MMS
Insider Buying and Selling at Maximus
In other Maximus news, insider Ilene R. Baylinson sold 14,500 shares of the business's stock in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.00. Following the sale, the insider now owns 2,512 shares in the company, valued at approximately $171,167.68. The trade was a 85.23% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Jan Madsen sold 2,439 shares of the business's stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the transaction, the director now directly owns 18,097 shares in the company, valued at $1,225,347.87. This trade represents a 11.88% decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.60% of the company's stock.
Maximus Trading Up 0.4%
NYSE:MMS opened at $75.34 on Friday. Maximus, Inc. has a fifty-two week low of $63.77 and a fifty-two week high of $93.97. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. The stock has a market capitalization of $4.26 billion, a PE ratio of 16.20 and a beta of 0.61. The business's 50-day simple moving average is $68.58 and its 200-day simple moving average is $72.84.
Maximus (NYSE:MMS - Get Free Report) last released its earnings results on Thursday, May 8th. The health services provider reported $2.01 EPS for the quarter, beating the consensus estimate of $1.37 by $0.64. The firm had revenue of $1.36 billion for the quarter, compared to analysts' expectations of $1.29 billion. Maximus had a return on equity of 21.95% and a net margin of 5.28%. The business's quarterly revenue was up 1.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.57 EPS. Sell-side analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.
Maximus Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th will be paid a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 1.59%. The ex-dividend date is Thursday, May 15th. Maximus's payout ratio is 23.86%.
Maximus Company Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.